AS part of its ongoing mission to provide care and support to those in need, The Mawar Haemodialysis Centre in Seremban has introduced subsidised dialysis rates that have made a significant difference for many patients.
Currently, 14 patients are paying only RM110 per dialysis session, 75 patients paying RM130, and 77 patients paying RM200. These rates are considerably lower than the average market rate of RM250 per session.
According to the chairman of the management board, Datuk Seri Lee Tian Hock, in 2024, with an average of 165 patients, even at the rate of RM200 per session, the hospital subsidised a total of RM1.28 million to ensure that treatment was affordable.
"By offering even lower rates of RM110 and RM130 per session, we have been able to further reduce financial pressure on our
patients, subsidising a total amount of RM1 million for those receiving these rates.
"We have also not forgotten the B40 group — the bottom 40% of our population who are most vulnerable. Through our welfare fund, we have been able to provide additional support, amounting to RM80,482.80, directly benefiting the B40 patients in our care," he said.
In total, the hospital subsidised RM2.37 million for its dialysis patients.
"This is a reflection of our dedication to not only improving lives but also alleviating the financial burdens that often come with medical treatments," said Lee.
Despite offering subsidized dialysis rates, Mawar Medical Centre Dialysis Division achieved remarkable financial results.
In 2024, it recorded a revenue of RM3.83 million, with a profit before tax of RM289,163, and a profit after tax of RM190,200. "These results reflect the careful and efficient management of our resources, ensuring that we remain sustainable
while staying true to our commitment to affordable healthcare," he said.
Lee added that at a time when private hospitals are often criticized for focusing solely on profits, Mawar Medical
Centre stands as a proud example of how a private healthcare institution can be both compassionate and community-focused.- January 18, 2025
